Current Applications for Overcoming Resistance to Targeted Therapies (Book, 1st ed. 2019)

Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. However, the development of resistance to these combinatorial approaches has led to the reassessment of currently available therapeutic options to overcome resistance to targeted therapy. This book aims to provide an update on the advancements in the therapeutic arms race between cancer, clinicians and scientists alike to overcome resistance to targeted therapies. Subject experts provide a comprehensive overview of the challenges and solutions to resistance to several conventional targeted therapies in addition to providing a discussion on broad topics including targeting components of the tumor microenvironment, emerging therapeutic options, and novel areas to be explored concerning nanotechnology and the epigenome.

General

Imprint:	Springer Nature Switzerland AG
Country of origin:	Switzerland
Series:	Resistance to Targeted Anti-Cancer Therapeutics, 20
Release date:	August 2019
First published:	2019
Editors:	Myron R. Szewczuk • Bessi Qorri • Manpreet Sambi
Dimensions:	235 x 155mm (L x W)
Format:	Book • Electronic book text
Pages:	320
Edition:	1st ed. 2019
ISBN-13:	978-3-03-021476-0
Categories:	Books > Medicine > General issues > Medical equipment & techniques > Medical research Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	3-03-021476-1
Barcode:	9783030214760

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!